Loading clinical trials...
Loading clinical trials...
This study was a single-center, single-dose, open-label study in healthy male subjects to investigate the absorption, metabolism and excretion of HRS9531 after a single subcutaneous injection of \[14C...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
NCT07223983 · Alcohol Use Disorder, Weight Loss, and more
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT07144800 · Obesity, Child Obesity, and more
NCT06811324 · Obesity Prevention, Sarcopenia in Elderly, and more
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions